1-20 of 163
Claudio Anasetti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Multicenter Trial of Sirolimus vs. Prednisone as Initial Therapy for Standard Risk Acute GVHD: BMT CTN 1501

Clinical Trials & Observations
Joseph Pidala, Mehdi Hamadani, Peter Dawson, Michael Martens, Amin M Alousi, Madan Jagasia, Yvonne Adeduni Efebera, Saurabh Chhabra, Iskra Pusic, Shernan G Holtan, James LM Ferrara, John E Levine, Marco Mielcarek, Claudio Anasetti, Joseph H. Antin, Javier Bolanos-Meade, Alan Howard, Brent R Logan, Eric Leifer, Theresa Salay Pritchard, Mary M Horowitz, Margaret L. MacMillan
Blood blood.2019003125.
DOI: https://doi.org/10.1182/blood.2019003125
Published: 2019
Journal Articles

Human CD83 Targeted Chimeric Antigen Receptor T Cell for the Prevention of Graft Versus Host Disease and Treatment of Myeloid Leukemia

Bishwas Shrestha, PhD, Kelly Walton, Jordan Reff, Elizabeth M. Sagatys, MD, Nhan Tu, PhD, Justin C. Boucher, PhD, Tayyeb Ghafoor, BS, Joseph Pidala, MD, Bruce R. Blazar, MD, Claudio Anasetti, MD, Brian C. Betts, MD, Marco L. Davila, MD PhD
Blood (2019) 134 (Supplement_1): 196.
DOI: https://doi.org/10.1182/blood-2019-124031
Published: 2019
Journal Articles

Outcomes of Hematopoietic Cell Transplantation in Acute Promyelocytic Leukemia - a Single Institution Experience

Hamza Hashmi, MD, Jeffrey Lancet, MD, Asmita Mishra, MD, Kendra L. Sweet, MD, Rami S. Komrokji, MD, Hugo F. Fernandez, MD, Lia Perez, MD, Farhad Khimani, MD, Michael Nieder, MD, Hany Elmariah, MD MS, Joseph Pidala, MD, Nelli Bejanyan, MD, Alan F. List, MD, Claudio Anasetti, MD, Taiga Nishihori, MD
Blood (2019) 134 (Supplement_1): 5739.
DOI: https://doi.org/10.1182/blood-2019-128985
Published: 2019
Journal Articles

Off-the-shelf TCR for graft-versus-leukemia without GVHD

Frederick L. Locke, Claudio Anasetti
Blood (2018) 131 (1): 5–7.
DOI: https://doi.org/10.1182/blood-2017-11-812990
Published: 2018
Journal Articles

Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201

Edmund K. Waller, MD, Brent R. Logan, PhD, Mingwei Fei, MS, Alan Howard, PhD, John R. Wingard, MD, Claudio Anasetti, MD, Cynthia R. Giver, PhD
Blood (2017) 130 (Supplement 1): 1972.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1972.1972
Published: 2017
Journal Articles

A Phase II Trial Evaluating the Use of the Histone Deacetylase Inhibitor Panobinostat for Graft-Versus-Host Disease (GVHD) Prevention

Lia Perez, MD, Hugo F. Fernandez, MD, Farhad Khimani, MBBS, Ernesto Ayala, MD, Mohamed A Kharfan-Dabaja, MD, Asmita Mishra, MD, Leonel Ochoa, MD, Brian C. Betts, MD, Joseph Pidala, MD PhD, Claudio Anasetti, MD
Blood (2017) 130 (Supplement 1): 1985.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1985.1985
Published: 2017
Journal Articles

Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201

Shanelle M. Fernando, Brent R. Logan, PhD, Mingwei Fei, MS, Stephanie J. Lee, MD PhD, Dennis Confer, MD, Alan Howard, PhD, Shanmuganathan Chandrakasan, MD, Cynthia R. Giver, PhD, Claudio Anasetti, MD, Edmund K. Waller, MD
Blood (2017) 130 (Supplement 1): 516.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.516.516
Published: 2017
Journal Articles

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Clinical Trials & Observations
Theo de Witte, David Bowen, Marie Robin, Luca Malcovati, Dietger Niederwieser, Ibrahim Yakoub-Agha, Ghulam J. Mufti, Pierre Fenaux, Guillermo Sanz, Rodrigo Martino, Emilio Paolo Alessandrino, Francesco Onida, Argiris Symeonidis, Jakob Passweg, Guido Kobbe, Arnold Ganser, Uwe Platzbecker, Jürgen Finke, Michel van Gelder, Arjan A. van de Loosdrecht, Per Ljungman, Reinhard Stauder, Liisa Volin, H. Joachim Deeg, Corey Cutler, Wael Saber, Richard Champlin, Sergio Giralt, Claudio Anasetti, Nicolaus Kröger
Blood (2017) 129 (13): 1753–1762.
DOI: https://doi.org/10.1182/blood-2016-06-724500
Published: 2017
Includes: Supplemental data
Journal Articles

Fludarabine and Melphalan Results in Fewer Relapses Compared to Fludarabine and Targeted Busulfan in Patients Receiving Reduced Intensity Conditioning for AML and MDS

Ryan James Caddell, PharmD, Braydon Schaible, MPH, Zhenjun Ma, PhD, Elizabeth Dimaggio, PharmD, BCOP, Rebecca Tombleson, PharmD, BCOP, Claudio Anasetti, MD, Ernesto Ayala, MD, Brian C. Betts, MD, Mohamed A. Kharfan-Dabaja, MD, Frederick L. Locke, MD, Taiga Nishihori, MD, Joseph A. Pidala, MD, Hugo F. Fernandez, MD, Asmita Mishra, MD
Blood (2016) 128 (22): 3486.
DOI: https://doi.org/10.1182/blood.V128.22.3486.3486
Published: 2016
Journal Articles

Comparison of Peripheral Blood Stem Cells (PBSC) to Bone Marrow (BM) for T-Replete HLA-Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide

Asad Bashey, MD PhD, MeiJie Zhang, PhD, Shannon R. McCurdy, Stefan O. Ciurea, MD, Andrew St. Martin, MS, Claudio Anasetti, MD, Trevor Argall, Omotayo O. Fasan, MBBS, MRCP, Sameh Gaballa, MD, Mehdi Hamadani, MD, Monzr M al Malki, MD, Pashna N. Munshi, MD, Ryotaro Nakamura, MD, Paul V. O'Donnell, MD PhD, Miguel-Angel Perales, MD, Kavita Raj, MDPhD, Vanderson Rocha, MD PhD, Rizwan Romee, MD, Scott D. Rowley, MD, Rachel Salit, MD, Melhem Solh, MD, Robert J. Soiffer, MD, John R. Wingard, MD, Daniel J. Weisdorf, MD, Mary M Horowitz, MD MS, Ephraim Joseph Fuchs, MD, Mary Eapen, MBBS
Blood (2016) 128 (22): 683.
DOI: https://doi.org/10.1182/blood.V128.22.683.683
Published: 2016
Journal Articles

Updated Outcomes of Fludarabine/Melphalan/Bortezomib (Flu/Mel/Vel) Conditioning for Upfront Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma

Taiga Nishihori, MD, Claudio Anasetti, MD, Rachid Baz, MD, Jose L Ochoa-Bayona, MD, Kenneth H. Shain, MD PhD, Ryan Hillgruber, Melissa Alsina, MD
Blood (2016) 128 (22): 5885.
DOI: https://doi.org/10.1182/blood.V128.22.5885.5885
Published: 2016
Journal Articles

Comparison of Total Body Irradiation-Based with Intravenous Busulfan-Based Chemotherapy-Only Conditioning Regimens for Myeloablative Hematopoietic Cell Transplantation (HCT) in Adults with Acute Lymphoblastic Leukemia

Partow Kebriaei, MD, Claudio Anasetti, MD, Mei-Jie Zhang, PhD, Hai-Lin Wang, MPH, Ibrahim Aldoss, MD, Marcos de Lima, MD, H. Jean Khoury, MD, Brenda M. Sandmaier, MD, Mary M. Horowitz, MD MS, Andrew Artz, MD MS, Nelli Bejanyan, MD, Stefan O. Ciurea, MD, Hillard M. Lazarus, MD, Robert Peter Gale, MD PhD, Mark Litzow, MD, Christopher N. Bredeson, MD MSc, FRCPC, Matthew D. Seftel, MBChB, FRCP(C), MRCP, Michael A Pulsipher, MD, Jaap Jan Boelens, MDPhD, Joseph Alvarnas, MD, Richard E. Champlin, MD, Stephen J. Forman, MD, Vinod Pullarkat, MD, Daniel Weisdorf, MD, David I. Marks, MD PhD
Blood (2016) 128 (22): 679.
DOI: https://doi.org/10.1182/blood.V128.22.679.679
Published: 2016
Journal Articles

Predicting relevant immunogenetic disparities

Joseph Pidala, Claudio Anasetti
Blood (2016) 128 (1): 12–13.
DOI: https://doi.org/10.1182/blood-2016-05-717512
Published: 2016
Journal Articles

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

Craig Kollman, Stephen R. Spellman, Mei-Jie Zhang, Anna Hassebroek, Claudio Anasetti, Joseph H. Antin, Richard E. Champlin, Dennis L. Confer, John F. DiPersio, Marcelo Fernandez-Viña, Robert J. Hartzman, Mary M. Horowitz, Carolyn K. Hurley, Chatchada Karanes, Martin Maiers, Carlheinz R. Mueller, Miguel-Angel Perales, Michelle Setterholm, Ann E. Woolfrey, Neng Yu, Mary Eapen
Blood (2016) 127 (2): 260–267.
DOI: https://doi.org/10.1182/blood-2015-08-663823
Published: 2016
Journal Articles

Body Composition Predicts Survival in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Asmita Mishra, MD, Binglin Yue, Martine Extermann, MD PhD, Claudio Anasetti, MD, Heather Jim, Jongphil Kim, Joseph A Pidala, MD, PhD, Vickie E Baracos
Blood (2015) 126 (23): 2113.
DOI: https://doi.org/10.1182/blood.V126.23.2113.2113
Published: 2015
Journal Articles

Targeting JAK2 By Gene Knockout or Pacritinib Treatment Reduces Gvhd and Xenograft Rejection By Promoting Induced Treg Differentiation

Brian C Betts, MD, David Bastian, Hung Nguyen, PhD, Jessica Lauren Heinrichs, BS, MS, Yongxia Wu, MD PhD, Anandharaman Veerapathran, PhD, Marie C Lee, MD, Jack Singer, MD, Claudio Anasetti, MD, Xue-Zhong Yu, MD MS
Blood (2015) 126 (23): 1874.
DOI: https://doi.org/10.1182/blood.V126.23.1874.1874
Published: 2015
Journal Articles

Impact of Splenomegaly in the Presence of Negative PET FDG Avidity on Allogeneic Hematopoietic Cell Transplant Outcomes in Patients with Lymphoid Malignancies

Farhad Khimani, MD, Daniel K. Jeong, MD, Taiga Nishihori, MD, Ernesto Ayala, MD, Joseph A Pidala, MD, PhD, Frederick L. Locke, MD, Gage Kenneth, Julio C. Chavez, MD, Claudio Anasetti, MD, Mohamed A. Kharfan-Dabaja, MD
Blood (2015) 126 (23): 5524.
DOI: https://doi.org/10.1182/blood.V126.23.5524.5524
Published: 2015
Journal Articles

TP53 and IDH2 Somatic Mutations Are Associated with Poor Outcomes Following Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Mohamed A. Kharfan-Dabaja, MD, Rami S. Komrokji, MD, Qing Zhang, PhD, David Sallman, MD, Asmita Mishra, MD, Najla H. Al Ali, BDS, MSc, Taiga Nishihori, MD, Teresa Field, MD, PhD, Karma Z Salem, MD, Janelle Perkins, PharmD, Ling Zhang, MD, Lynn C. Moscinski, MD, Hugo F. Fernandez, MD, Jeffrey E Lancet, MD, Alan F. List, MD, Claudio Anasetti, MD, Eric Padron, MD
Blood (2015) 126 (23): 4382.
DOI: https://doi.org/10.1182/blood.V126.23.4382.4382
Published: 2015
Journal Articles

Hypo-Albuminemia at Day+90 after Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies Independently Predicts for Inferior Overall Survival and Higher Non-Relapse Mortality

Josephine Emole, MD, Mohamed A. Kharfan-Dabaja, MD, Julio C Chavez, MD, Taiga Nishihori, MD, Marcie Riches, MD, Asmita Mishra, MD, Binglin Yue, Jongphil Kim, Ernesto Ayala, MD, Claudio Anasetti, MD, Frederick L Locke, MD
Blood (2015) 126 (23): 4407.
DOI: https://doi.org/10.1182/blood.V126.23.4407.4407
Published: 2015
Journal Articles

CD4 Treg and CD4 Tcon Utilize Distinct TCR Vbeta Repertoires in Response to Alloantigen

Anandharaman Veerapathran, PhD, Micheal Schell, PhD, Francisca Beato, B.S, TzuHua Juan, MPH, Sean Yoder, M.S, Brian C Betts, MD, Joseph A Pidala, MD, PhD, Claudio Anasetti, MD
Blood (2015) 126 (23): 4286.
DOI: https://doi.org/10.1182/blood.V126.23.4286.4286
Published: 2015